AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to tame immune attack after stem cell transplants
Disease control Not yet recruitingThis study tests a combination of the drug Gecacitinib and steroids as a first treatment for acute graft-versus-host disease (aGVHD), a serious complication after a stem cell transplant. About 25 adults who have already received a transplant and developed moderate to severe aGVHD…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: Bin Gu • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug may shield transplant patients from deadly immune attack
Disease control Not yet recruitingThis study tests whether the drug ivarmacitinib can prevent acute graft-versus-host disease (aGVHD) in 32 people with blood cancers receiving a stem cell transplant from a half-matched donor. aGVHD occurs when donor immune cells attack the patient's body. The study will measure h…
Matched conditions: AGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:57 UTC